Why is cj stroud struggling

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Yes, it is possible to get HPV after vaccination, but the risk is significantly reduced. Current HPV vaccines protect against the most common high-risk and low-risk HPV types that cause the majority of HPV-related cancers and genital warts. However, they do not protect against all existing HPV strains.

Key Facts

HPV vaccines protect against the most common and dangerous HPV strains.
The vaccines significantly reduce the risk of HPV infection and related diseases.
Not all HPV types are covered by current vaccines.
Vaccination is most effective when administered before sexual activity begins.
Regular screening for cervical cancer is still recommended even after vaccination.

Overview

The Human Papillomavirus (HPV) is a very common sexually transmitted infection that can lead to several types of cancer, including cervical, anal, oral, and genital cancers, as well as genital warts. Vaccination against HPV has become a cornerstone of public health strategies aimed at preventing these diseases. The vaccines are designed to stimulate an immune response against specific HPV types, preventing infection if an individual is exposed.

While the HPV vaccines are highly effective, a crucial question arises: can you still get HPV if you are vaccinated? The answer is nuanced. The vaccines offer robust protection against the HPV types that are responsible for the vast majority of HPV-related infections and diseases. However, they are not a 'silver bullet' that eradicates all possible HPV strains. Therefore, while the risk is dramatically lowered, it is not entirely eliminated.

How It Works

Targeted Protection: HPV vaccines are designed to target specific high-risk HPV types (like HPV 16 and 18, which cause about 70% of cervical cancers) and certain low-risk types (like HPV 6 and 11, responsible for about 90% of genital warts). The vaccine contains virus-like particles (VLPs) that mimic the outer shell of the virus but cannot cause infection. When injected, these VLPs trigger the immune system to produce antibodies.
Immune Response: Upon subsequent exposure to the actual HPV types covered by the vaccine, these antibodies are ready to neutralize the virus, preventing it from infecting cells and causing disease. This pre-emptive action is key to the vaccine's effectiveness in preventing long-term health issues.
Limited Strain Coverage: It is important to understand that current HPV vaccines do not cover all of the over 200 known HPV types. While they cover the most prevalent and oncogenic (cancer-causing) strains, there are other HPV types that are not included in the vaccine's formulation. Infection with one of these non-vaccine types is still possible even after vaccination.
Duration of Immunity and Booster Doses: Studies have shown that the immunity conferred by HPV vaccines is long-lasting, with protection observed for at least a decade. As of now, routine booster doses are not recommended by major health organizations for individuals who have completed the primary vaccination series. However, research is ongoing to fully understand the long-term duration of protection.

Key Comparisons

Feature	HPV Vaccine (Current)	Natural HPV Infection
Protection Against Specific Types	High (covers most common high-risk and low-risk types)	Variable (depends on the specific HPV type encountered)
Risk of Cancer	Significantly Reduced	Increased risk for certain HPV types
Prevention of Genital Warts	Significantly Reduced	Possible if infected with covered types
Coverage of All HPV Types	No (covers a subset of over 200 types)	No (does not provide immunity against all types)
Need for Screening	Recommended (especially for cervical cancer)	Highly Recommended

Why It Matters

Impact: Prevention of Cancers: The impact of HPV vaccination on cancer prevention is profound. In countries with high vaccination rates, there has been a dramatic decrease in precancerous cervical lesions and a projected decline in cervical cancer rates in the coming decades. This translates to thousands of lives saved annually and a significant reduction in the burden of cancer treatment.
Impact: Reduction of Genital Warts: Beyond cancer prevention, the vaccine also significantly reduces the incidence of genital warts, a common and often recurrent manifestation of HPV infection. This not only improves quality of life but also reduces the strain on healthcare resources for treating this condition.
Impact: Herd Immunity: When a large proportion of a population is vaccinated, it creates herd immunity, which indirectly protects unvaccinated individuals, including those who cannot be vaccinated for medical reasons or who are too young to receive the vaccine. This collective protection is a critical public health benefit.

In conclusion, while the HPV vaccine is not 100% protective against every single HPV strain, it offers an exceptionally high level of defense against the types that cause the most serious health consequences. It remains one of the most effective tools in preventing HPV-related cancers and genital warts. Therefore, it is highly recommended for adolescents and young adults to get vaccinated as recommended by public health authorities. Coupled with regular health screenings, vaccination provides the best defense against the broader spectrum of HPV-related diseases.